Unlock the promise of gene therapy and gene editing
Gene Therapy R&D Solutions
Benchling’s Gene Therapy R&D Solutions are trusted by leading gene therapy innovators to accelerate their R&D. The Solutions enable scientists to study gene editing and gene therapy technologies at scale with improved productivity, intuitive collaboration, and contextual insights. Our modern, digital solutions combine the capabilities of traditional ELN, LIMS, and molecular biology tools in a unified cloud solution that natively supports gene therapy R&D.
The Gene Therapy R&D Accelerators provide best practices that shorten time-to-value for research and process development. The Accelerators contain:
Data model – entity relationship diagram (ERD) which serves as an implementation blueprint
Tenant configuration – pre-defined tenant configuration using templates and dashboards for registering entities, tracking results, increasing inventory utilization, and streamlining workflows
Solution Guide – highlight capabilities and latest product features
Benchling’s services support customers from implementation through ongoing success.
See Benchling's Gene and Cell Therapy R&D Solutions in action
How we deliver
Our Customer Experience professionals possess deep scientific expertise, as well as training on information technology best practices. They apply this know-how to support gene therapy customers across a wide range of R&D teams.
Leverage Benchling's pre-implementation solutions consulting, professional implementation services, and customer success management expertise to help you get the most out of Benchling.
Focused R&D Support
Take advantage of Benchling’s foundational implementation guides, developed by our Customer Experience team to support many gene therapy R&D functions, including:
CRISPR gene editing